Skip to main content
Caplight Logo









PakGent Bioscience

PakGent Bioscience

Private
SuzhouHealthcare & Life Scienceshttps://www.pakgentbio.com/

Last Round

Angel

Apr 13, 2023

Momentum

Top 50%

of companies Caplight tracks

Company Overview

PakGent Bioscience operates in Healthcare & Life Sciences and is based in Suzhou. Its latest recorded funding round was an Angel round in April 2023.

PakGent Bioscience is a biotechnology company that manufactures laboratory consumables, including pipette tips, PCR products, cell culture consumables, and other liquid handling products.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Medical Devices, Biotechnology, Smart Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

PakGent Bioscience Comparables

Compare PakGent Bioscience with similar companies based on industry and business-model similarity.

PakGent Bioscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Zhejiang Bioland Biotechnology Co., Ltd.
91%
Changde BKMAM Biotechnology Co., Ltd.
90%
Suzhou Cotaus Biomedical Technology Co., Ltd.
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

PakGent Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelApr 13, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

PakGent Bioscience Investors

Notable investors and investment history

PakGent Bioscience investors
InvestorRounds
Yuan Ming CapitalAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Open roles increased to 4, 8x the trailing average.

  • Feb 16, 2025

    Added Rosesci, a Life Sciences / Lab Automation startup.

Book a demo to see all signals

For institutional investors. Book with your work email.

PakGent Bioscience Filings

Explore SEC and related filing metadata, where available.

PakGent Bioscience filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about PakGent Bioscience's valuation, stock price, and market status.

Is PakGent Bioscience a public or private company?

PakGent Bioscience is a private company.

What is the current stock price of PakGent Bioscience?

PakGent Bioscience is a private company, so its shares have no public market price. Caplight tracks PakGent Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is PakGent Bioscience worth (valuation)?

Valuation information for PakGent Bioscience is not publicly available.

Can I buy PakGent Bioscience stock?

PakGent Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was PakGent Bioscience's last funding round?

PakGent Bioscience's most recent funding round was Angel on April 13, 2023.

Who are the main investors in PakGent Bioscience?

Key investors in PakGent Bioscience include Yuan Ming Capital.

Will PakGent Bioscience IPO soon?

No public IPO plans have been announced for PakGent Bioscience.

How can I track PakGent Bioscience secondary market activity?

Caplight tracks bids, offers, and trades in PakGent Bioscience's shares on secondary markets.

Firmographic Details

HeadquartersSuzhou
Employee Range6
Year Founded2020
Last FundingApr 13, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?